Differential regulation of the cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 by phosphorylation directed by the cyclin encoded by Murine Herpesvirus 68

Experimental Cell Research

Volumn 314, Issue 1, 2008, Pages 204-212

  Yarmishyn, Aliaksandr ^a   Child, Emma S ^a   Elphick, Lucy M ^a   Mann, David J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cdk2; Cell cycle; Cyclin; Cyclin dependent kinase; Herpesvirus; p21Cip1; p27Kip1; Phosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; HOLOENZYME; THREONINE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HERPES VIRUS; HERPES VIRUS 68; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; T WAVE;

HERPESVIRIDAE; MAMMALIA; MURID HERPESVIRUS 4;

EID: 36549021684     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.09.016     Document Type: Article

References (37)

1. Helt A.M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 (2003) 159-169
2. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
3. Sherr C.J., and Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 (2004) 2699-2711
4. Cannell E., and Mittnacht S. Viral encoded cyclins. Semin. Cancer Biol. 9 (1999) 221-229
5. Laman H., Mann D.J., and Jones N.C. Viral-encoded cyclins. Curr. Opin. Genet. Dev. 10 (2000) 70-74
6. Mittnacht S., and Boshoff C. Viral cyclins. Rev. Med. Virol. 10 (2000) 175-184
7. Swanton C., Card G.L., Mann D., McDonald N., and Jones N. Overcoming inhibitions: subversion of CKI function by viral cyclins. Trends Biochem. Sci. 24 (1999) 116-120
8. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
9. Chang Y., Moore P.S., Talbot S.J., Boshoff C.H., Zarkowska T., Godden K., Paterson H., Weiss R.A., and Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 382 (1996) 410
10. Godden-Kent D., Talbot S.J., Boshoff C., Chang Y., Moore P., Weiss R.A., and Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71 (1997) 4193-4198
11. Li M., Lee H., Yoon D.W., Albrecht J.C., Fleckenstein B., Neipel F., and Jung J.U. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71 (1997) 1984-1991
12. Ellis M., Chew Y.P., Fallis L., Freddersdorf S., Boshoff C., Weiss R.A., Lu X., and Mittnacht S. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18 (1999) 644-653
13. Mann D.J., Child E.S., Swanton C., Laman H., and Jones N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18 (1999) 654-663
14. Swanton C., Mann D.J., Fleckenstein B., Neipel F., Peters G., and Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390 (1997) 184-187
15. Virgin H.W.t., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., and Speck S.H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71 (1997) 5894-5904
16. Jung J.U., Stager M., and Desrosiers R.C. Virus-encoded cyclin. Mol. Cell. Biol. 14 (1994) 7235-7244
17. Card G.L., Knowles P., Laman H., Jones N., and McDonald N.Q. Crystal structure of a gamma-herpesvirus cyclin-cdk complex. EMBO J. 19 (2000) 2877-2888
18. van Dyk L.F., Hess J.L., Katz J.D., Jacoby M., Speck S.H., and Virgin H.I. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J. Virol. 73 (1999) 5110-5122
19. Jarviluoma A., Child E.S., Sarek G., Sirimongkolkasem P., Peters G., Ojala P.M., and Mann D.J. Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest. Mol. Cell. Biol. 26 (2006) 2430-2440
20. Mann D.J., and Jones N.C. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol. 6 (1996) 474-483
21. Child E.S., and Mann D.J. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene 20 (2001) 3311-3322
22. Gu Y., Rosenblatt J., and Morgan D.O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11 (1992) 3995-4005
23. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287 (1999) 821-828
24. Brown A.J., Jones T., and Shuttleworth J. Expression and activity of p40MO15, the catalytic subunit of cdk-activating kinase, during Xenopus oogenesis and embryogenesis. Mol. Biol. Cell 5 (1994) 921-932
25. Poon R.Y., Yamashita K., Adamczewski J.P., Hunt T., and Shuttleworth J. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J. 12 (1993) 3123-3132
26. Tassan J.P., Schultz S.J., Bartek J., and Nigg E.A. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127 (1994) 467-478
27. Kaldis P., Ojala P.M., Tong L., Makela T.P., and Solomon M.J. CAK-independent activation of CDK6 by a viral cyclin. Mol. Biol. Cell 12 (2001) 3987-3999
28. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., and Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11 (1997) 1464-1478
29. Vlach J., Hennecke S., and Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16 (1997) 5334-5344
30. Bloom J., and Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13 (2003) 41-47
31. Verschuren E.W., Klefstrom J., Evan G.I., and Jones N. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2 (2002) 229-241
32. Aleem E., Kiyokawa H., and Kaldis P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat. Cell Biol. 7 (2005) 831-836
33. Geng Y., Yu Q., Sicinska E., Das M., Schneider J.E., Bhattacharya S., Rideout W.M., Bronson R.T., Gardner H., and Sicinski P. Cyclin E ablation in the mouse. Cell 114 (2003) 431-443
34. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1 (2002) 226-231
35. Meyerson M., Enders G.H., Wu C.L., Su L.K., Gorka C., Nelson C., Harlow E., and Tsai L.H. A family of human cdc2-related protein kinases. EMBO J. 11 (1992) 2909-2917
36. Ye X., Zhu C., and Harper J.W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1682-1686
37. Upton J.W., van Dyk L.F., and Speck S.H. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology 341 (2005) 271-283